Clinical trials
Recruiting Alzheimer Disease trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 12 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 4 |
| Washington University School of Medicine | 3 |
| Alnylam Pharmaceuticals | 2 |
| Denali Therapeutics Inc. | 2 |
| Imperial College London | 2 |
| University of Cambridge | 2 |
| AC Immune SA | 1 |
| Brain Health Scotland Life Sciences Ltd | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 31 |
| Dementia | 17 |
| Cognitive Dysfunction | 8 |
| Brain Diseases | 3 |
| Central Nervous System Diseases | 3 |
| Down Syndrome | 2 |
| Mental Disorders | 2 |
| Nervous System Diseases | 2 |
| Pick Disease of the Brain | 2 |
| Psychomotor Agitation | 2 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.